A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesis

Xiaoxue Qiu1, Guijie Guo, Ke Chen

  • 1CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.

Neoplasia (New York, N.Y.)
|July 13, 2012
PubMed

Insights

Bcr-Abl oncoproteins overcome Suppressors of Cytokine Signaling (SOCS-1/3) inhibition through tyrosine phosphorylation, enhancing JAK/STAT signaling. This phosphorylation is crucial for Bcr-Abl-mediated tumorigenesis and leukemic cell survival.

Area of Science:

  • Molecular Biology
  • Oncology
  • Signal Transduction

Background:

  • Suppressors of cytokine signaling (SOCS-1 and SOCS-3) are key negative regulators of the Janus tyrosine kinase (JAK)/signal transducers and activators of transcription (STAT) pathway.
  • Constitutive activation of JAK/STAT signaling is a hallmark of Abl-driven leukemias, but the mechanisms by which Abl oncoproteins evade SOCS-mediated inhibition are not fully understood.

Purpose of the Study:

  • To elucidate the mechanism by which Bcr-Abl oncoproteins overcome SOCS-1 and SOCS-3 inhibitory regulation.
  • To investigate the role of Bcr-Abl-induced tyrosine phosphorylation of SOCS proteins in regulating JAK/STAT signaling and mediating tumorigenesis.

Main Methods:

  • Coexpression of Bcr-Abl with SOCS-1 or SOCS-3 in cellular systems.
  • Analysis of tyrosine phosphorylation sites on SOCS proteins using mass spectrometry.
  • Assessment of JAK/STAT pathway activation and downstream target gene expression (e.g., Bcl-X(L)).
  • In vivo studies using nude mice and murine bone marrow transformation assays to evaluate tumorigenesis.

Main Results:

  • Bcr-Abl induces tyrosine phosphorylation of SOCS-1 and SOCS-3, primarily at specific tyrosine residues (Tyr155/204 for SOCS-1, Tyr221 for SOCS-3).
  • This phosphorylation facilitates SOCS binding to Bcr-Abl, diminishes their inhibitory capacity on JAK/STAT5 signaling, and enhances pathway activation.
  • Disruption of SOCS tyrosine phosphorylation impairs Bcl-X(L) expression, sensitizes cells to apoptosis, and significantly blocks Bcr-Abl-mediated tumorigenesis in vivo.

Conclusions:

  • Bcr-Abl overcomes SOCS-1 and SOCS-3 inhibition via tyrosine phosphorylation, leading to constitutive JAK/STAT activation.
  • Tyrosine phosphorylation of SOCS proteins is a critical mechanism for Bcr-Abl-mediated oncogenesis, impacting cell survival and tumor development.
  • Targeting SOCS tyrosine phosphorylation represents a potential therapeutic strategy for Bcr-Abl-associated malignancies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...